GXO Logistics, Inc. — Q1 2024 Form 10-Q
Business context and period: Unaudited results for the three months ended March 31, 2024, compared with Q1 2023. GXO is a global contract logistics provider reporting one operating segment. The quarter’s results include PFS, acquired in October 2023; Wincanton was acquired after quarter-end.
Financial results
Amounts in millions, except per-share data and percentages.
| Metric | Q1 2024 | Q1 2023 |
|---|---|---|
| Revenue | $2,456 | $2,323 |
| Operating income (loss) | $(39) | $42 |
| Net income (loss) attributable to GXO | $(37) | $25 |
| Diluted EPS | $(0.31) | $0.21 |
| Cash from operating activities | $50 | $39 |
| Capital expenditures | $73 | $91 |
- Revenue increased 6% ($133), primarily reflecting $63 from PFS and $50 from favorable foreign currency movements.
- Direct operating expense rose 8% to $2,056, faster than revenue; it was 83.7% of revenue versus 82.0% a year earlier. SG&A declined $9 to $249. Operating margin was approximately -1.6%, versus 1.8% in Q1 2023.
- Operating results included a $63 litigation expense related to a customer dispute. Excluding that item is not a company-reported adjusted result in the provided filing text.
- Net interest expense was $13 in both periods. The company recorded a $10 tax benefit in 2024 versus $3 tax expense in 2023.
- Operating cash flow rose $11 to $50. Investing cash outflow was $82 in both periods; financing cash outflow improved to $8 from $29. Cash, restricted cash and equivalents decreased $45 to $425 during the quarter.
Balance sheet and liquidity
- At March 31, cash and cash equivalents were $423; current assets were $2,463 and current liabilities $2,625.
- Total debt carrying value was $1,637, including $126 current and $1,511 long-term. The balance sheet separately reported operating lease liabilities of $2,433. No amounts were outstanding under the revolving credit facility or acquisition-related term facilities at quarter-end.
- The new five-year revolving facility provides $800 of commitments; management reported $799 of borrowing capacity net of letters of credit. GXO said cash, operating cash flows, the revolver and factoring programs should provide sufficient liquidity for at least the next 12 months.
- GXO sold $291 of receivables through non-recourse factoring in Q1, receiving $289 in cash consideration.
Material developments, outlook and risks
- Wincanton: GXO agreed to a cash offer of 605 pence per share and purchased approximately 2.0 million shares for $15 in March. Wincanton shareholders approved the deal April 10; GXO completed the acquisition April 29 for approximately £762 million ($953 million), including shares purchased beforehand. The U.K. Competition and Markets Authority was reviewing the acquisition, with completion of its review estimated in the second half of 2024.
- To fund the acquisition, GXO issued $1.1 billion of senior notes in May: $600 million at 6.25% due 2029 and $500 million at 6.50% due 2034. It also repaid $100 million of its 2027 term loan on May 6. These are post-quarter events and were not reflected in March 31 debt balances.
- Litigation: A jury returned verdicts for a customer in March over a 2018 warehouse start-up dispute. GXO recorded $63 of expense for the verdicts, potential post-trial interest, legal fees and related costs; it intends to pursue post-verdict remedies, including an appeal, and seek insurance reimbursement. The ultimate outcome and recovery are uncertain.
- Remaining performance obligations were approximately $3.7 billion at March 31; GXO expects to recognize about 75% over the next three years. Actual amounts may vary with foreign exchange, contract changes or terminations.
- The filing provides no specific earnings or revenue guidance. Management noted that operating results may be affected by contract start-up timing and working-capital needs. GXO reported compliance with debt covenants and no material change to previously disclosed risk factors or market-risk exposure.
Important facts for investors to verify
- Potential litigation exposure beyond the $63 accrued expense, the appeal process and the extent and timing of insurance recovery.
- Wincanton integration, CMA review outcome, acquisition funding costs and the resulting leverage and interest burden.
- Whether operating costs, particularly personnel and temporary labor, moderate relative to revenue growth and margins recover.
- Cash conversion, factoring use, capital spending and the availability of liquidity as acquisition-related obligations and debt maturities evolve.
- Performance-obligation estimates and revenue growth composition, including currency effects and acquired-business contribution.